deCODE genetics, Inc.

deCODE genetics, Inc.

deCODE genetics, Inc.

Overview
Date Founded

1996

Headquarters

Sturlugata 8,Reykjavík 110

Type of Company

Private

Industries

Pharmaceuticals
Commercial Scientific Research

Company Description

deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland.

Website
Paths to deCODE genetics, Inc.
Potential Connections via
Relationship Science
You
deCODE genetics, Inc.
Recent Transactions
Details Hidden

ARCH Venture Partners, Polaris Partners, Saga Investments LLC purchase deCODE genetics from deCODE genetics, Inc.

Details Hidden

deCODE genetics, Inc. purchases Urdur Verdandi Skuld

Details Hidden

deCODE genetics, Inc. purchases MediChem Life Sciences, Inc.

Subscribe now to see full list of recent transations
Transaction Advisors
Legal Advisor

Advised ondeCODE genetics, Inc. purchases MediChem Life Sciences, Inc.

Manager

Advised ondeCODE genetics, Inc. issued Common Stock

Underwriter

Advised ondeCODE genetics, Inc. issued Common Stock

Subscribe now to see 4+ more transaction advisors
Corporate Officer

Advised ondeCODE genetics, Inc. issued Common Stock

Corporate Officer

Advised ondeCODE genetics, Inc. issued Common Stock

Subscribe now to see transaction advisors for over 2.5 million organizations